Spread of Klebsiella pneumoniae carbapenemase-2-producing Klebsiella pneumoniae clones in Asia

Future Microbiology

Volumn 9, Issue 3, 2014, Pages 273-275

  Jean, Shio Shin ^a   Hsueh, Po Ren ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

amikacin; carbapenem; China; colistin; combination therapy; Klebsiella pneumoniae carbapenemase; sequence type 11; Taiwan; tigecycline

Indexed keywords

AMIKACIN; CARBAPENEM; COLISTIN; IMIPENEM; MEROPENEM; TIGECYCLINE; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE-2, KLEBSIELLA PNEUMONIAE;

ANTIBIOTIC SENSITIVITY; ASIA; BACTERIAL GENE; BACTERIUM ISOLATE; CLONE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; GENETICS; HUMAN; KLEBSIELLA INFECTIONS; PHYSIOLOGY; TRANSMISSION;

ASIA; BACTERIAL PROTEINS; BETA-LACTAMASES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

EID: 84899563583     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.157     Document Type: Review

References (21)

1. Liu SW, Chang HJ, Chia JH, Kuo AJ, Wu TL, Lee MH. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: A matched case-control study. J. Microbiol. Immunol. Infect. 45(2), 113-119 (2012
2. Qureshi ZA, Paterson DL, Potoski BA et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens. Antimicrob. Agents. Chemother. 56(4), 2108-2113 (2012
3. Tumbarello M, Viale P, Viscoli C et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumonia carbapenemase-producing K. pneumoniae: Importance of combination therapy. Clin. Infect. Dis. 55(7), 943-950 (2012
4. Jean SS, Lee WS, Hsueh PR. Nationwide spread of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan. J. Microbiol. Immunol. Infect. 46(5), 317-319 (2013
5. Centers for Disease Control and Prevention of Taiwan. The monitor report, from Taiwanese Nosocomial Infection Surveillance System, in the third quarter of 2012 (written in Chinese). www.taichung.gov.tw/public/ Data/31411292471.pdf
6. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J. Antimicrob. Chemother. 66(2), 307-312 (2011
7. Ma L, Lu PL, Siu LK, Hsieh MH. Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: Results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. J. Med. Microbiol. 62(1), 101-107 (2013
8. Hung KH, Yan JJ, Lu JJ, Chen HM, Wu JJ. Characterization of the modified Hodge test-positive isolates of Enterobacteriaceae in Taiwan. J. Microbiol. Immunol. Infect. 46(1), 35-40 (2013
9. Chung KP, Tseng SP, Huang YT, Tsai TH, Teng LJ, Hsueh PR. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. J. Antimicrob. Chemother. 66(5), 1182-1184 (2011
10. Lee CM, Liao CH, Lee WS et al. Outbreak of Klebsiella pneumonia carbapenemase-2-producing K. pneumonia sequence type 11 in Taiwan in 2011. Antimicrob. Agents. Chemother. 56(10), 5016-5022 (2012
11. Chiu SK, Wu TL, Chuang YC et al. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: The emergence and rapid dissemination of KPC-2 carbapenemase. PLoS ONE 8(7), e69428-e69434 (2013
12. Balm MN, Ngan G, Jureen R, Lin RT, Teo J. Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. J. Clin. Microbiol. 50(2), 475-476 (2012
13. Koyano S, Saito R, Nagai R et al. Molecular characterization of carbapenemase-producing clinical isolates of Enterobacteriaceae in a teaching hospital, Japan. J. Med. Microbiol. 62(3), 446-450 (2013
14. Yoo JS, Kim HM, Yoo JI et al. Detection of clonal KPC-2-producing Klebsiella pneumonia ST258 in Korea during nationwide surveillance in 2011. J. Med. Microbiol. 62(9), 1338-1342 (2013
15. Zowawi HM, Balkhy HH, Walsh TR, Paterson DL. β-lactamase production in key Gram-negative pathogen isolates from the Arabian Peninsula. Clin. Microbiol. Rev. 26(3), 361-380 (2013
16. Chen YT, Lin JC, Fung CP et al. KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. J. Antimicrob. Chemother. doi:10.1093/jac/ dkt409 (2013) (Epub ahead of print
17. Huang SR, Liu MF, Lin CF, Shi ZY. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections. J. Microbiol. Immunol. Infect. doi:10.1016/j.jmii.08.029 (2012) (Epub ahead of print
18. Spanu T, De Angelis G, Cipriani M et al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents. Chemother. 56(8), 4516-4518 (2012
19. Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J. Clin. Microbiol. 47(5), 1611-1612 (2009
20. Kuti JL, Dandekar PK, Nightingale CH, Nicolau DP. Use of Monte Carlo simulation to design an optimized pharmacodynamics dosing strategy for meropenem. J. Clin. Pharmacol. 43(10), 1116-1123 (2003
21. Lee GC, Burgess DS. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: A review of published case series and case reports. Ann. Clin. Microbiol. Antimicrob. 11, 32-40 (2012.